Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Scott Perrin

Vascular & Interventional Radiology Sarasota, FL Medical Doctor

NPI 1033373980 CMS profile 1383911

1801 S Osprey Ave Ste 100, Sarasota, FL 34239

Open in the dashboard

General payments

$10,748

203 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$60,937 paid to institutions, not to them · program years 2020–2025

Through program year 2025, Scott Perrin of Sarasota, FL is reported in the CMS Open Payments database as having received $10,748 across 203 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $60,937 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 78th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,228 31
2024 General $1,053 27
2023 General $2,609 31
2022 General $2,713 48
2021 General $1,244 24
2020 General $345 18
2019 General $1,556 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Perrin
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Scott Perrin were reported at $1,228. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Scott Perrin Vascular & Interventional Radiology median Middle half National median
2019 $1,556 $422 $125–$1,555 $163
2020 $345 $200 $68–$652 $114
2021 $1,244 $280 $99–$866 $132
2022 $2,713 $433 $137–$1,497 $149
2023 $2,609 $506 $152–$2,019 $160
2024 $1,053 $556 $175–$1,930 $164
2025 $1,228 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $3,436 41 payments
  2. Boston Scientific Corporation $1,496 43 payments
  3. Ethicon US, LLC $1,208 9 payments
  4. Penumbra, Inc. $1,074 34 payments
  5. Medtronic, Inc. $598 11 payments
  6. Surefire Medical, Inc. $548 12 payments
  7. Sirtex Medical Inc $368 5 payments
  8. Stryker Corporation $267 8 payments
  9. Abbott Laboratories $221 3 payments
  10. Medtronic Vascular, Inc. $215 10 payments
  11. Other $1,317 27 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,301 200 payments
  2. Honoraria $1,500 1 payment
  3. Consulting Fee $600 1 payment
  4. Travel and Lodging $347 1 payment
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $3,712 48 payments
  2. CT THROMBECTOMY SYSTEM KIT $3,602 46 payments
  3. Indigo System $832 19 payments
  4. NEUWAVE Flex Microwave Ablation System $799 3 payments
  5. TRINAV INFUSION SYSTEM $548 12 payments
  6. SIR-Spheres Microspheres $344 4 payments
  7. GENERAL EMBOLICS $331 7 payments
  8. General - Embolics $276 10 payments
  9. RUBY Coil $227 14 payments
  10. SUPERA $198 2 payments
  11. Other $3,109 76 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

64

Median for Interventional Radiology: 38

Drug cost

$298

Median for Interventional Radiology: $333

Branded share of claims

0%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 64 $298

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 290 billing codes

Paid by Medicare

$240,887

Of which drugs: $601

Medicare patients

3,030

Average age 78

Services billed

8,105

1,462 women, 1,568 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Ischemic heart disease 57%
Atrial fibrillation 42%
Chronic kidney disease 38%
Heart failure 37%
Diabetes 33%
Depression 33%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 43 3,160 $316
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml A9579 Office 13 240 $285

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

203 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record